Advertisement
Canadian Journal of Cardiology
Clinical Research| Volume 32, ISSUE 3, P327-335, March 2016

The Underestimated Belly Factor: Waist Circumference Is Linked to Significant Morbidity Following Isolated Coronary Artery Bypass Grafting

      Abstract

      Background

      Waist circumference (WC) and body mass index (BMI) are clinically used to assess adiposity. The aim of the present study was to evaluate the association of WC with postoperative morbidity and mortality in patients who underwent isolated coronary artery bypass grafting (CABG) in relation to patients' BMI category.

      Methods

      We analyzed the associations of WC and BMI with short-term postoperative outcomes in a cohort of 7446 patients who underwent isolated CABG. We performed univariate and adjusted analyses on main postoperative outcomes after CABG for WC and BMI.

      Results

      Adverse events researched included postoperative mortality, intensive care unit and hospital length of stay, cardiovascular and cerebrovascular events, respiratory complications, infectious, hemostasis complications, and renal complications. WC was independently associated with all postoperative outcomes except prolonged intubation and mortality. Overall, patients in the upper WC quartile in each BMI category were at increased risk of adverse events compared with patients in the lower 3 WC quartiles, with a maximal incremental risk of 1.91 (95% confidence interval, 1.23-2.95) among patients with a BMI ≥ 35. This association was observed for men and women, across all overweight and obesity categories. Neither WC nor BMI was associated with short-term postoperative mortality.

      Conclusions

      In our large cohort of patients who underwent isolated CABG, WC was significantly associated with clinical adverse events, independently of BMI. These findings provide further evidence on the added value of measuring WC as a simple and easy to measure anthropometric marker to refine risk assessment beyond BMI among patients who undergo CABG.

      Résumé

      Introduction

      Dans la pratique clinique, le tour de taille et l’indice de masse corporelle (IMC) sont utilisés pour évaluer l’adiposité. Le but de la présente étude consistait à évaluer le lien entre le tour de taille et la morbidité/mortalité postopératoires chez des patients ayant subi un pontage aorto-coronarien isolé en relation avec leur catégorie d’IMC.

      Méthodes

      Nous avons analysé le lien entre le tour de taille, l’IMC et les résultats postopératoires à court terme dans une cohorte de 7 446 patients ayant subi un pontage aorto-coronarien isolé. Nous avons réalisé des analyses univariées multivariées avec ajustement sur les principaux résultats postopératoires après un pontage aorto-coronarien, pour le tour de taille et l’IMC.

      Résultats

      Les événements indésirables analysés comprenaient la mortalité postopératoire, la durée du séjour à l’hôpital et aux soins intensifs, les manifestations cardiovasculaires et vasculaires cérébrales, les complications respiratoires, les infections, l’hémostasie et les complications rénales. Nous avons établi association indépendante entre le tour de taille et tous les résultats postopératoires, à l’exception de l’intubation prolongée et de la mortalité. D’une manière générale, les patients ayant un tour de taille se situant dans le quartile supérieur dans chacune des catégories d’IMC étaient exposés à un risque accru d’événements indésirables, comparativement à ceux dont le tour de taille se situait dans les trois quartiles inférieurs, le rapport de cote maximal étant de 1,91 (intervalle de confiance à 95 % : 1,23 – 2,95) chez les patients dont l’IMC était ≥ 35. Cette association a été observé chez les hommes et chez les femmes, dans toutes les catégories de surpoids et d’obésité. Ni le tour de taille ni l’IMC n’ont été associés à la mortalité postopératoire à court terme.

      Conclusions

      Dans notre vaste cohorte de patients ayant subi un pontage aorto-coronarien isolé, une association significative a été étabeli entre le tour de taille et certains événements indésirables cliniques, indépendamment de l’IMC. Ces résultats viennent confirmer l’intérêt du tour de taille en tant que marqueur anthropométrique simple et facile à mesurer pour mieux évaluer le risque, au-delà de l’IMC, chez les patients qui subissent un pontage aorto-coronarien.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gregg E.W.
        • Cheng Y.J.
        • Narayan K.M.
        • Thompson T.J.
        • Williamson D.F.
        The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004.
        Prev Med. 2007; 45: 348-352
        • Granton J.
        • Cheng D.
        Risk stratification models for cardiac surgery.
        Semin Cardiothorac Vasc Anesth. 2008; 12: 167-174
        • Jin R.
        • Grunkemeier G.L.
        • Furnary A.P.
        • Handy J.R.
        Is obesity a risk factor for mortality in coronary artery bypass surgery?.
        Circulation. 2005; 111: 3359-3365
        • Engelman D.T.
        • Adams D.H.
        • Byrne J.G.
        • et al.
        Impact of body mass index and albumin on morbidity and mortality after cardiac surgery.
        J Thorac Cardiovasc Surg. 1999; 118: 866-873
        • Reeves B.C.
        • Ascione R.
        • Chamberlain M.H.
        • Angelini G.D.
        Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery.
        J Am Coll Cardiol. 2003; 42: 668-676
        • Prabhakar G.
        • Haan C.K.
        • Peterson E.D.
        • et al.
        The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons’ database.
        Ann Thorac Surg. 2002; 74 ([discussion: 1130-1]): 1125-1130
        • Wagner B.D.
        • Grunwald G.K.
        • Rumsfeld J.S.
        • et al.
        Relationship of body mass index with outcomes after coronary artery bypass graft surgery.
        Ann Thorac Surg. 2007; 84: 10-16
        • Habib R.H.
        • Zacharias A.
        • Schwann T.A.
        • et al.
        Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis.
        Ann Thorac Surg. 2005; 79: 1976-1986
        • Cornier M.A.
        • Després J.P.
        • Davis N.
        • et al.
        Assessing adiposity: a scientific statement from the American Heart Association.
        Circulation. 2011; 124: 1996-2019
      1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–The Evidence Report [erratum in 1998;6:464]. National Institutes of Health.
        Obes Res. 1998; 6: 51S-209S
        • Echahidi N.
        • Mohty D.
        • Pibarot P.
        • et al.
        Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.
        Circulation. 2007; 116: I213-I219
        • Leiter L.A.
        • Fitchett D.H.
        • Gupta R.E.
        • et al.
        Identification and management of cardiometabolic risk in Canada: a position paper by the Cardiometabolic Risk Working Group (Executive summary).
        Can J Cardiol. 2011; 27: 124-131
        • Potapov E.
        Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery.
        Eur Heart J. 2003; 24: 1933-1941
        • Romero-Corral A.
        • Montori V.M.
        • Somers V.K.
        • et al.
        Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.
        Lancet. 2006; 368: 666-678
        • Sönmez K.
        • Akçakoyun M.
        • Akçay A.
        • et al.
        Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio).
        Int J Obes Relat Metab Disord. 2003; 27: 341-346
        • Echahidi N.
        • Pibarot P.
        • Després J.
        • et al.
        Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery.
        J Am Coll Cardiol. 2007; 50: 843-851
        • Nazare J.
        • Smith J.
        • Borel A.
        • et al.
        Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA Study).
        Am J Cardiol. 2015; 115: 307-315
        • Bastien M.
        • Poirier P.
        • Lemieux I.
        • Després J.P.
        Overview of epidemiology and contribution of obesity to cardiovascular disease.
        Prog Cardiovasc Dis. 2014; 56: 369-381
        • Després J.P.
        Body fat distribution and risk of cardiovascular disease: an update.
        Circulation. 2012; 126: 1301-1313
        • Després J.P.
        Obesity and cardiovascular disease: weight loss is not the only target.
        Can J Cardiol. 2015; 31: 216-222
        • Garcia-Labbé D.
        • Ruka E.
        • Bertrand O.F.
        • et al.
        Obesity and coronary artery disease: evaluation and treatment.
        Can J Cardiol. 2015; 31: 184-194
        • Hajer G.R.
        • van Haeften T.W.
        • Visseren F.L.
        Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
        Eur Heart J. 2008; 29: 2959-2971
        • Zacharias A.
        • Schwann T.A.
        • Riordan C.J.
        • et al.
        Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
        Circulation. 2005; 112: 3247-3255
        • Poirier P.
        • Giles T.D.
        • Bray G.A.
        • et al.
        Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical.
        Circulation. 2006; 113: 898-918
        • Girerd N.
        • Pibarot P.
        • Fournier D.
        • et al.
        Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery.
        Eur Heart J. 2009; 30: 1270-1278
        • Lellouche F.
        • Dionne S.
        • Simard S.
        • Bussières J.
        • Dagenais F.
        High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery.
        Anesthesiology. 2012; 116: 1072-1082
        • Babb T.G.
        • DeLorey D.S.
        • Wyrick B.L.
        • Gardner P.P.
        Mild obesity does not limit change in end-expiratory lung volume during cycling in young women.
        J Appl Physiol. 2002; 92: 2483-2490
        • DeLorey D.S.
        • Wyrick B.L.
        • Babb T.G.
        Mild-to-moderate obesity: implications for respiratory mechanics at rest and during exercise in young men.
        Int J Obes (Lond). 2005; 29: 1039-1047
        • Poirier P.
        • Alpert M.A.
        • Fleisher L.A.
        • et al.
        Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association.
        Circulation. 2009; 120: 86-95
        • Baslaim G.
        • Bashore J.
        • Alhoroub K.
        Impact of obesity on early outcomes after cardiac surgery: experience in a Saudi Arabian center.
        Ann Thorac Cardiovasc Surg. 2008; 14: 369-375
        • Yap C.H.
        • Mohajeri M.
        • Yii M.
        Obesity and early complications after cardiac surgery.
        Med J Aust. 2007; 186: 350-354
        • Rothaar R.C.
        • Epstein S.K.
        Extubation failure: magnitude of the problem, impact on outcomes, and prevention.
        Curr Opin Crit Care. 2003; 9: 59-66
        • Behazin N.
        • Jones S.B.
        • Cohen R.I.
        • Loring S.H.
        Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity.
        J Appl Physiol. 2010; 108: 212-218
        • Lassnigg A.
        • Schmidlin D.
        • Mouhieddine M.
        • et al.
        Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.
        J Am Soc Nephrol. 2004; 15: 1597-1605
        • Conlon P.J.
        • Stafford-Smith M.
        • White W.D.
        • et al.
        Acute renal failure following cardiac surgery.
        Nephrol Dial Transplant. 1999; 14: 1158-1162
        • McGuinness J.
        • Bouchier-Hayes D.
        • Redmond J.M.
        Understanding the inflammatory response to cardiac surgery.
        Surgeon. 2008; 6: 162-171
        • Rodrigues A.J.
        • Roberto P.
        • Evora B.
        • et al.
        Risk factors for acute renal failure after heart surgery.
        Rev Bras Cir Cardiovasc. 2009; 24: 441-446
        • Pan W.
        • Hindler K.
        • Lee V.V.
        • Vaughn W.K.
        • Collard C.D.
        Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity.
        Anesthesiology. 2006; 104: 441-447
        • Filsoufi F.
        • Castillo J.G.
        • Rahmanian P.B.
        • et al.
        Epidemiology of deep sternal wound infection in cardiac surgery.
        J Cardiothorac Vasc Anesth. 2009; 23: 488-494
        • Spelman D.W.
        • Russo P.
        • Harrington G.
        • et al.
        Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery.
        Aust N Z J Surg. 2000; 70: 47-51
        • Wigfield C.H.
        • Lindsey J.D.
        • Muñoz A.
        • et al.
        Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or = 40.
        Eur J Cardiothorac Surg. 2006; 29: 434-440
        • Shammas N.W.
        Pulmonary embolus after coronary artery bypass surgery: a review of the literature.
        Clin Cardiol. 2000; 23: 637-644
        • Després J.P.
        • Lemieux I.
        Abdominal obesity and metabolic syndrome.
        Nature. 2006; 444: 881-887